As president and CEO of TraceLink,Inc., Shabbir Dahod leads a visionary team that helps companies meet the complex requirements of the Drug Supply Chain Security Act.
In this annual plasma-themed issue of BioSupply Trends Quarterly, we take a critical look at the current plasma market, especially issues of supply and demand.
At age 41, Eric Jordan suffered a massive ischemic stroke and lost his ability to speak.
Dr. Philip Meyers treats vascular disorders of the brain and spinal cord using minimally invasive, image-guided techniques.
As we peer into the not-too-distant future, is it possible that some of the treatments that seem so innovative today will also be looked back upon as unsophisticated?
From a bi-weekly newsletter to an award-winning quarterly magazine, BioSupply Trends Quarterly has grown to be a timely, trustworthy source for biopharmaceutical news.
Dr. Craig Kessler has been a specialist in acquired hemophilia since the late 1980s.
As CEO of FFF Enterprises, Inc., Patrick Schmidt takes pride in his company’s success in helping to secure the specialty biopharmaceuticals marketplace over the past 26 years.
When Alice Dunkley was diagnosed with inherited chronic obstructive pulmonary disease (COPD), she was given less than five years to live. Twenty-six years later, this active grandmother continues to beat the odds.
Dr. Barbara P. Yawn shares Important aspects of testing, therapies and exacerbations of COPD that every primary care physician should know.
A deeper look at major risks in the healthcare industry, including lack of preventative care, inadequate care, adverse drug reactions and counterfeit drugs.
As U.S. Director of Sales & Marketing, Influenza, Chris Woolway is creating strategic partnerships to address industry challenges.